142 related articles for article (PubMed ID: 1348155)
1. An immunohistological demonstration of c-erbB-2 oncoprotein expression in primary urothelial bladder cancer.
Gardiner RA; Samaratunga ML; Walsh MD; Seymour GJ; Lavin MF
Urol Res; 1992; 20(2):117-20. PubMed ID: 1348155
[TBL] [Abstract][Full Text] [Related]
2. Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
Coombs LM; Pigott DA; Sweeney E; Proctor AJ; Eydmann ME; Parkinson C; Knowles MA
Br J Cancer; 1991 Apr; 63(4):601-8. PubMed ID: 1673627
[TBL] [Abstract][Full Text] [Related]
3. Use of immunohistochemically demonstrated c-erb B-2 oncoprotein expression as a prognostic factor in transitional cell carcinoma of the urinary bladder.
Lipponen P; Eskelinen M; Syrjänen S; Tervahauta A; Syrjänen K
Eur Urol; 1991; 20(3):238-42. PubMed ID: 1688050
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer.
Lipponen P
Eur J Cancer; 1993; 29A(5):749-53. PubMed ID: 8097100
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder.
Berner A; Jacobsen AB; Fosså SD; Nesland JM
Histopathology; 1993 Apr; 22(4):327-33. PubMed ID: 8099896
[TBL] [Abstract][Full Text] [Related]
6. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
Wright C; Mellon K; Johnston P; Lane DP; Harris AL; Horne CH; Neal DE
Br J Cancer; 1991 Jun; 63(6):967-70. PubMed ID: 1712624
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the expression of oncogenes ras and c-erbB-2 and the biological behavior of bladder tumors.
Ye DW; Zheng JF; Qian SX; Ma YJ
Urol Res; 1993 Jan; 21(1):39-43. PubMed ID: 8096102
[TBL] [Abstract][Full Text] [Related]
8. An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma.
Sato K; Moriyama M; Mori S; Saito M; Watanuki T; Terada K; Okuhara E; Akiyama T; Toyoshima K; Yamamoto T
Cancer; 1992 Nov; 70(10):2493-8. PubMed ID: 1358427
[TBL] [Abstract][Full Text] [Related]
9. c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder.
Lunec J; Challen C; Wright C; Mellon K; Neal DE
Lancet; 1992 Feb; 339(8790):439-40. PubMed ID: 1346710
[No Abstract] [Full Text] [Related]
10. [C-erbB-2 oncogene amplification in breast cancer in correlation to steroid and epidermal growth factor receptor].
Manavi M; Czerwenka KF; Zeillinger R; Speiser P; Kury F; Steinhart U; Peschke M; Kubista E; Reinold E
Zentralbl Gynakol; 1992; 114(2):82-5. PubMed ID: 1350129
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of c-erbB-2 oncoprotein in muscle-invasive bladder carcinoma: relationship with gene amplification, clinicopathological parameters and prognostic outcome.
Krüger S; Weitsch G; Büttner H; Matthiensen A; Böhmer T; Marquardt T; Sayk F; Feller AC; Böhle A
Int J Oncol; 2002 Nov; 21(5):981-7. PubMed ID: 12370744
[TBL] [Abstract][Full Text] [Related]
12. c-jun oncogene expression in transitional cell carcinoma of the urinary bladder.
Tiniakos DG; Mellon K; Anderson JJ; Robinson MC; Neal DE; Horne CH
Br J Urol; 1994 Dec; 74(6):757-61. PubMed ID: 7827848
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical localization of c-erbB-2 protein in transitional cell carcinoma of the urinary bladder.
Coombs LM; Oliver S; Sweeney E; Knowles M
J Pathol; 1993 Jan; 169(1):35-42. PubMed ID: 8094432
[TBL] [Abstract][Full Text] [Related]
14. c-myc oncoprotein levels in bladder cancer.
Masters JR; Vesey SG; Munn CF; Evan GI; Watson JV
Urol Res; 1988; 16(5):341-4. PubMed ID: 3059654
[TBL] [Abstract][Full Text] [Related]
15. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
[TBL] [Abstract][Full Text] [Related]
16. Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique.
Orlando C; Sestini R; Vona G; Pinzani P; Bianchi S; Giacca M; Pazzagli M; Selli C
J Urol; 1996 Dec; 156(6):2089-93. PubMed ID: 8911396
[TBL] [Abstract][Full Text] [Related]
17. Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer.
Zhau HE; Zhang X; von Eschenbach AC; Scorsone K; Babaian RJ; Ro JY; Hung MC
Mol Carcinog; 1990; 3(5):254-7. PubMed ID: 1978777
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.
Wright C; Angus B; Nicholson S; Sainsbury JR; Cairns J; Gullick WJ; Kelly P; Harris AL; Horne CH
Cancer Res; 1989 Apr; 49(8):2087-90. PubMed ID: 2564806
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
[TBL] [Abstract][Full Text] [Related]
20. Her-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder.
Montie JE
J Urol; 2005 Jun; 173(6):1921-2. PubMed ID: 15879779
[No Abstract] [Full Text] [Related]
[Next] [New Search]
